Sunesis Pharmaceuticals Inc (VIRX)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Mark A. Rothera
Employees:
20
2533 S COAST HWY 101, SUITE 210, CARDIFF, CA, 92007
858-400-8470
-
Formally known as:
- Sunesis Pharmaceuticals Inc.
- Sunesis Pharmaceuticals, Inc.
Date | Ratio |
---|---|
2011-02-15 | 1:6 |
2016-09-08 | 1:6 |
2020-09-03 | 1:10 |
Viracta Therapeutics, Inc. engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir. The company's development pipeline includesvecabrutinib, a clinical-stage non-covalent ITK/BTK inhibitor and VRx-510.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|